Learn how artificial intelligence is used to design AI antibodies, marking a milestone in protein design and treatment innovation.

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.

In this webinar, Jae Chang Lim and Hyun Joon Chang will discuss how a cutting-edge artificial intelligence platform is transforming early-stage drug discovery.

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

The field of oncology continues to confront the formidable challenge of addressing cancer, a leading cause of mortality ...

Pharma companies are collaborating to boost the power of artificial intelligence (AI) in drug discovery by allowing access to proprietary structural data to train a large language model. Each of the ...

Avner Schlessinger, PhD, right, working with his lab researchers at Mount Sinai AI Small Molecule Drug Discovery Center in New York City. [Mount Sinai] Most breakthrough discoveries are made based on ...

FRESNO, Calif. (KFSN) -- As artificial intelligence evolves, we're seeing a number of industries use AI to their advantage. Now, pharmaceutical companies are leaning into the technology to speed the ...

Existing frameworks for explainable artificial intelligence (XAI) and AI governance, such as the EU AI Act and the NIST AI ...

This story is part of Fast Company’s 2025 Innovation by Design Awards. Explore the full list of companies creating products, reimagining spaces, and working to design a better world. Read more about ...